Inhibition of JNK reduces steatosis and steatohepatitis of the liver in HFD-induced rats (Yan et al., 2017), and decreases fat accumulation in human HepG2 hepatoma cells via the ROS/JNK/AP-1 signaling (Xie et al., 2021). Here, JUN is linked to steatosis.